Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-02-22

AUTHORS

Massimiliano Ruscica, Chiara Pavanello, Sara Gandini, Chiara Macchi, Margherita Botta, Daria Dall’Orto, Marina Del Puppo, Marco Bertolotti, Raffaella Bosisio, Giuliana Mombelli, Cesare R. Sirtori, Laura Calabresi, Paolo Magni

ABSTRACT

BACKGROUND: Probiotics incorporated into dairy products have been shown to reduce total (TC) and LDL cholesterolemia (LDL-C) in subjects with moderate hypercholesterolemia. More specifically, probiotics with high biliary salt hydrolase activity, e.g. Bifidobacterium longum BB536, may decrease TC and LDL-C by lowering intestinal cholesterol reabsorption and, combined with other nutraceuticals, may be useful to manage hypercholesterolemia in subjects with low cardiovascular (CV) risk. This study was conducted to evaluate the efficacy and safety of a nutraceutical combination containing Bifidobacterium longum BB536, red yeast rice (RYR) extract (10 mg/day monacolin K), niacin, coenzyme Q10 (Lactoflorene Colesterolo®). The end-points were changes of lipid CV risk markers (LDL-C, TC, non-HDL-cholesterol (HDL-C), triglycerides (TG), apolipoprotein B (ApoB), HDL-C, apolipoprotein AI (ApoAI), lipoprotein(a) (Lp(a), proprotein convertase subtilisin/kexin type 9 (PCSK9)), and of markers of cholesterol synthesis/absorption. METHODS: A 12-week randomized, parallel, double-blind, placebo-controlled study. Thirty-three subjects (18-70 years) in primary CV prevention and low CV risk (SCORE: 0-1% in 24 and 2-4% in 9 subjects; LDL-C: 130-200 mg/dL) were randomly allocated to either nutraceutical (N = 16) or placebo (N = 17). RESULTS: Twelve-week treatment with the nutraceutical combination, compared to placebo, significantly reduced TC (- 16.7%), LDL-C (- 25.7%), non-HDL-C (- 24%) (all p < 0.0001), apoB (- 17%, p = 0.003). TG, HDL-C, apoAI, Lp(a), PCSK9 were unchanged. Lathosterol:TC ratio was significantly reduced by the nutraceutical combination, while campesterol:TC ratio and sitosterol:TC ratio did not change, suggesting reduction of synthesis without increased absorption of cholesterol. No adverse effects and a 97% compliance were observed. CONCLUSIONS: A 12-week treatment with a nutraceutical combination containing the probiotic Bifidobacterium longum BB536 and RYR extract significantly improved the atherogenic lipid profile and was well tolerated by low CV risk subjects. TRIAL REGISTRATION: NCT02689934 . More... »

PAGES

13

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12937-019-0438-2

DOI

http://dx.doi.org/10.1186/s12937-019-0438-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112315627

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30795775


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bifidobacterium longum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Products", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dietary Supplements", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypercholesterolemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Niacin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Placebos", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Probiotics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ubiquinone", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ruscica", 
        "givenName": "Massimiliano", 
        "id": "sg:person.01164502750.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164502750.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro E. Grossi Paoletti, Universit\u00e0 degli Studi di Milano, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy", 
            "Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro E. Grossi Paoletti, Universit\u00e0 degli Studi di Milano, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pavanello", 
        "givenName": "Chiara", 
        "id": "sg:person.01152414131.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152414131.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.15667.33", 
          "name": [
            "Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gandini", 
        "givenName": "Sara", 
        "id": "sg:person.0600005230.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600005230.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Macchi", 
        "givenName": "Chiara", 
        "id": "sg:person.01331664466.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331664466.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Botta", 
        "givenName": "Margherita", 
        "id": "sg:person.016575557672.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016575557672.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dall\u2019Orto", 
        "givenName": "Daria", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dipartimento di Medicina e Chirurgia, Universit\u00e0 degli Studi di Milano Bicocca, Monza, Italy", 
          "id": "http://www.grid.ac/institutes/grid.7563.7", 
          "name": [
            "Dipartimento di Medicina e Chirurgia, Universit\u00e0 degli Studi di Milano Bicocca, Monza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Del Puppo", 
        "givenName": "Marina", 
        "id": "sg:person.01207302233.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207302233.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Universit\u00e0 degli Studi di Modena e Reggio Emilia, Modena, Italy", 
          "id": "http://www.grid.ac/institutes/grid.7548.e", 
          "name": [
            "Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Universit\u00e0 degli Studi di Modena e Reggio Emilia, Modena, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bertolotti", 
        "givenName": "Marco", 
        "id": "sg:person.0676162076.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676162076.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro Dislipidemie, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Centro Dislipidemie, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bosisio", 
        "givenName": "Raffaella", 
        "id": "sg:person.01134006757.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134006757.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro Dislipidemie, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Centro Dislipidemie, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mombelli", 
        "givenName": "Giuliana", 
        "id": "sg:person.01313104616.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313104616.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro Dislipidemie, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Centro Dislipidemie, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sirtori", 
        "givenName": "Cesare R.", 
        "id": "sg:person.01042354223.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042354223.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro E. Grossi Paoletti, Universit\u00e0 degli Studi di Milano, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy", 
            "Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro E. Grossi Paoletti, Universit\u00e0 degli Studi di Milano, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Calabresi", 
        "givenName": "Laura", 
        "id": "sg:person.0771471774.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771471774.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "IRCCS MultiMedica, Sesto S. Giovanni, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.420421.1", 
          "name": [
            "Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy", 
            "IRCCS MultiMedica, Sesto S. Giovanni, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Magni", 
        "givenName": "Paolo", 
        "id": "sg:person.01341064336.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341064336.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12937-016-0213-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047786796", 
          "https://doi.org/10.1186/s12937-016-0213-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrendo.2017.78", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090367122", 
          "https://doi.org/10.1038/nrendo.2017.78"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-017-0580-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090379297", 
          "https://doi.org/10.1007/s12325-017-0580-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00294629", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036979684", 
          "https://doi.org/10.1007/bf00294629"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12906-015-0576-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009756976", 
          "https://doi.org/10.1186/s12906-015-0576-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11886-017-0848-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084808918", 
          "https://doi.org/10.1007/s11886-017-0848-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.ejcn.1602910", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015359962", 
          "https://doi.org/10.1038/sj.ejcn.1602910"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-02-22", 
    "datePublishedReg": "2019-02-22", 
    "description": "BACKGROUND: Probiotics incorporated into dairy products have been shown to reduce total (TC) and LDL cholesterolemia (LDL-C) in subjects with moderate hypercholesterolemia. More specifically, probiotics with high biliary salt hydrolase activity, e.g. Bifidobacterium longum BB536, may decrease TC and LDL-C by lowering intestinal cholesterol reabsorption and, combined with other nutraceuticals, may be useful to manage hypercholesterolemia in subjects with low cardiovascular (CV) risk. This study was conducted to evaluate the efficacy and safety of a nutraceutical combination containing Bifidobacterium longum BB536, red yeast rice (RYR) extract (10\u2009mg/day monacolin K), niacin, coenzyme Q10 (Lactoflorene Colesterolo\u00ae). The end-points were changes of lipid CV risk markers (LDL-C, TC, non-HDL-cholesterol (HDL-C), triglycerides (TG), apolipoprotein B (ApoB), HDL-C, apolipoprotein AI (ApoAI), lipoprotein(a) (Lp(a), proprotein convertase subtilisin/kexin type 9 (PCSK9)), and of markers of cholesterol synthesis/absorption.\nMETHODS: A 12-week randomized, parallel, double-blind, placebo-controlled study. Thirty-three subjects (18-70\u2009years) in primary CV prevention and low CV risk (SCORE: 0-1% in 24 and 2-4% in 9 subjects; LDL-C: 130-200\u2009mg/dL) were randomly allocated to either nutraceutical (N\u2009=\u200916) or placebo (N\u2009=\u200917).\nRESULTS: Twelve-week treatment with the nutraceutical combination, compared to placebo, significantly reduced TC (-\u200916.7%), LDL-C (-\u200925.7%), non-HDL-C (-\u200924%) (all p\u2009<\u20090.0001), apoB (-\u200917%, p\u2009=\u20090.003). TG, HDL-C, apoAI, Lp(a), PCSK9 were unchanged. Lathosterol:TC ratio was significantly reduced by the nutraceutical combination, while campesterol:TC ratio and sitosterol:TC ratio did not change, suggesting reduction of synthesis without increased absorption of cholesterol. No adverse effects and a 97% compliance were observed.\nCONCLUSIONS: A 12-week treatment with a nutraceutical combination containing the probiotic Bifidobacterium longum BB536 and RYR extract significantly improved the atherogenic lipid profile and was well tolerated by low CV risk subjects.\nTRIAL REGISTRATION: NCT02689934 .", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12937-019-0438-2", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031283", 
        "issn": [
          "1475-2891"
        ], 
        "name": "Nutrition Journal", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "keywords": [
      "Bifidobacterium longum BB536", 
      "longum BB536", 
      "low cardiovascular risk", 
      "CV risk markers", 
      "red yeast rice extract", 
      "LDL cholesterolemia", 
      "cardiovascular risk", 
      "nutraceutical combination", 
      "moderate hypercholesterolemia", 
      "risk markers", 
      "cholesterol reabsorption", 
      "coenzyme Q10", 
      "hypercholesterolemia", 
      "BB536", 
      "probiotics", 
      "rice extract", 
      "dairy products", 
      "subjects", 
      "hydrolase activity", 
      "cholesterolemia", 
      "LDL", 
      "niacin", 
      "reabsorption", 
      "efficacy", 
      "total", 
      "risk", 
      "markers", 
      "safety", 
      "nutraceuticals", 
      "Q10", 
      "extract", 
      "activity", 
      "study", 
      "changes", 
      "combination", 
      "Tc", 
      "products", 
      "high biliary salt hydrolase activity", 
      "biliary salt hydrolase activity", 
      "salt hydrolase activity", 
      "intestinal cholesterol reabsorption", 
      "yeast rice (RYR) extract", 
      "lipid CV risk markers"
    ], 
    "name": "Nutraceutical approach for the management of cardiovascular risk \u2013 a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study", 
    "pagination": "13", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112315627"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12937-019-0438-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30795775"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12937-019-0438-2", 
      "https://app.dimensions.ai/details/publication/pub.1112315627"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:46", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_824.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12937-019-0438-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12937-019-0438-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12937-019-0438-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12937-019-0438-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12937-019-0438-2'


 

This table displays all metadata directly associated to this object as RDF triples.

297 TRIPLES      22 PREDICATES      92 URIs      77 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12937-019-0438-2 schema:about N01e45dced05344e8b854e29a2e2542e1
2 N0875640652cd4101a3f900bcb0d205ab
3 N4c76421bf6ff4a448696e83bfc4e1ed4
4 N65d765eeb1fc49389eb94916f919638f
5 N663a85491ee7425aaeffa6262b81adc8
6 N68315211dff0469eaf590d1489615ee7
7 N748b7b0e35024599a497f72816a32b00
8 N9b0ca0c224ce41e5806d4099d04694e2
9 N9e85a80784c54ec886c7c8c463b27a0d
10 Na223ec2dcd8b47c681bda48333e1cbf5
11 Nb77eba3555664d879a8beab5d8b0274a
12 Nbe9aacfc93a44258b855e8f4eccaf714
13 Nc0f3257a5f1840c1bf5b05e9df9350da
14 Ndba81f4fd5a94669ae02ac2df34c3eea
15 Ne47f7c842eaf466298ee4abac467dc74
16 Nf46acd7bc88b48c8a25708372f58d821
17 anzsrc-for:11
18 anzsrc-for:1102
19 schema:author N6731923c0ace49159357c611398e9131
20 schema:citation sg:pub.10.1007/bf00294629
21 sg:pub.10.1007/s11886-017-0848-8
22 sg:pub.10.1007/s12325-017-0580-1
23 sg:pub.10.1038/nrendo.2017.78
24 sg:pub.10.1038/sj.ejcn.1602910
25 sg:pub.10.1186/s12906-015-0576-9
26 sg:pub.10.1186/s12937-016-0213-6
27 schema:datePublished 2019-02-22
28 schema:datePublishedReg 2019-02-22
29 schema:description BACKGROUND: Probiotics incorporated into dairy products have been shown to reduce total (TC) and LDL cholesterolemia (LDL-C) in subjects with moderate hypercholesterolemia. More specifically, probiotics with high biliary salt hydrolase activity, e.g. Bifidobacterium longum BB536, may decrease TC and LDL-C by lowering intestinal cholesterol reabsorption and, combined with other nutraceuticals, may be useful to manage hypercholesterolemia in subjects with low cardiovascular (CV) risk. This study was conducted to evaluate the efficacy and safety of a nutraceutical combination containing Bifidobacterium longum BB536, red yeast rice (RYR) extract (10 mg/day monacolin K), niacin, coenzyme Q10 (Lactoflorene Colesterolo®). The end-points were changes of lipid CV risk markers (LDL-C, TC, non-HDL-cholesterol (HDL-C), triglycerides (TG), apolipoprotein B (ApoB), HDL-C, apolipoprotein AI (ApoAI), lipoprotein(a) (Lp(a), proprotein convertase subtilisin/kexin type 9 (PCSK9)), and of markers of cholesterol synthesis/absorption. METHODS: A 12-week randomized, parallel, double-blind, placebo-controlled study. Thirty-three subjects (18-70 years) in primary CV prevention and low CV risk (SCORE: 0-1% in 24 and 2-4% in 9 subjects; LDL-C: 130-200 mg/dL) were randomly allocated to either nutraceutical (N = 16) or placebo (N = 17). RESULTS: Twelve-week treatment with the nutraceutical combination, compared to placebo, significantly reduced TC (- 16.7%), LDL-C (- 25.7%), non-HDL-C (- 24%) (all p < 0.0001), apoB (- 17%, p = 0.003). TG, HDL-C, apoAI, Lp(a), PCSK9 were unchanged. Lathosterol:TC ratio was significantly reduced by the nutraceutical combination, while campesterol:TC ratio and sitosterol:TC ratio did not change, suggesting reduction of synthesis without increased absorption of cholesterol. No adverse effects and a 97% compliance were observed. CONCLUSIONS: A 12-week treatment with a nutraceutical combination containing the probiotic Bifidobacterium longum BB536 and RYR extract significantly improved the atherogenic lipid profile and was well tolerated by low CV risk subjects. TRIAL REGISTRATION: NCT02689934 .
30 schema:genre article
31 schema:inLanguage en
32 schema:isAccessibleForFree true
33 schema:isPartOf N28bf6aa53fc446e58c2f3008ef9cbba5
34 Nac26607a13e648e2b432434fcfd58905
35 sg:journal.1031283
36 schema:keywords BB536
37 Bifidobacterium longum BB536
38 CV risk markers
39 LDL
40 LDL cholesterolemia
41 Q10
42 Tc
43 activity
44 biliary salt hydrolase activity
45 cardiovascular risk
46 changes
47 cholesterol reabsorption
48 cholesterolemia
49 coenzyme Q10
50 combination
51 dairy products
52 efficacy
53 extract
54 high biliary salt hydrolase activity
55 hydrolase activity
56 hypercholesterolemia
57 intestinal cholesterol reabsorption
58 lipid CV risk markers
59 longum BB536
60 low cardiovascular risk
61 markers
62 moderate hypercholesterolemia
63 niacin
64 nutraceutical combination
65 nutraceuticals
66 probiotics
67 products
68 reabsorption
69 red yeast rice extract
70 rice extract
71 risk
72 risk markers
73 safety
74 salt hydrolase activity
75 study
76 subjects
77 total
78 yeast rice (RYR) extract
79 schema:name Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
80 schema:pagination 13
81 schema:productId N487375cd87fe42ca9b833115ea474b45
82 N509280c690f546d3aec77fc4ab4fe9b4
83 Nbfb4618834cb4f6abc67f2dcc7aa0894
84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112315627
85 https://doi.org/10.1186/s12937-019-0438-2
86 schema:sdDatePublished 2021-12-01T19:46
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher N98e31330c33041bdafc0194ea2ab3d60
89 schema:url https://doi.org/10.1186/s12937-019-0438-2
90 sgo:license sg:explorer/license/
91 sgo:sdDataset articles
92 rdf:type schema:ScholarlyArticle
93 N01e45dced05344e8b854e29a2e2542e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Risk Factors
95 rdf:type schema:DefinedTerm
96 N02ce8eac42e143a987d36586082ee376 rdf:first Nd47302f0484d4e63abb9b3f339a40d17
97 rdf:rest N6b064a526cad47168a07865d5b8f1cbd
98 N0875640652cd4101a3f900bcb0d205ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Probiotics
100 rdf:type schema:DefinedTerm
101 N28bf6aa53fc446e58c2f3008ef9cbba5 schema:volumeNumber 18
102 rdf:type schema:PublicationVolume
103 N2cdc0c580adb480198917610f8f60371 rdf:first sg:person.0600005230.87
104 rdf:rest Nf87caea029804a47957f27e10f2085bd
105 N3b6ca8a33297474ba81505a06d710105 rdf:first sg:person.01134006757.62
106 rdf:rest Nf73ddedf03eb4f1993fe505c04d60812
107 N487375cd87fe42ca9b833115ea474b45 schema:name dimensions_id
108 schema:value pub.1112315627
109 rdf:type schema:PropertyValue
110 N4c76421bf6ff4a448696e83bfc4e1ed4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Female
112 rdf:type schema:DefinedTerm
113 N509280c690f546d3aec77fc4ab4fe9b4 schema:name doi
114 schema:value 10.1186/s12937-019-0438-2
115 rdf:type schema:PropertyValue
116 N65d765eeb1fc49389eb94916f919638f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Cardiovascular Diseases
118 rdf:type schema:DefinedTerm
119 N663a85491ee7425aaeffa6262b81adc8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Humans
121 rdf:type schema:DefinedTerm
122 N6731923c0ace49159357c611398e9131 rdf:first sg:person.01164502750.58
123 rdf:rest N78bc67f347a340d4a5cf61a8989205e8
124 N68315211dff0469eaf590d1489615ee7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Male
126 rdf:type schema:DefinedTerm
127 N6b064a526cad47168a07865d5b8f1cbd rdf:first sg:person.01207302233.42
128 rdf:rest N781e08e4bb1c422488855aedb3f6a88d
129 N748b7b0e35024599a497f72816a32b00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Placebos
131 rdf:type schema:DefinedTerm
132 N781e08e4bb1c422488855aedb3f6a88d rdf:first sg:person.0676162076.83
133 rdf:rest N3b6ca8a33297474ba81505a06d710105
134 N78bc67f347a340d4a5cf61a8989205e8 rdf:first sg:person.01152414131.16
135 rdf:rest N2cdc0c580adb480198917610f8f60371
136 N98e31330c33041bdafc0194ea2ab3d60 schema:name Springer Nature - SN SciGraph project
137 rdf:type schema:Organization
138 N9b0ca0c224ce41e5806d4099d04694e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Hypercholesterolemia
140 rdf:type schema:DefinedTerm
141 N9e85a80784c54ec886c7c8c463b27a0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Double-Blind Method
143 rdf:type schema:DefinedTerm
144 Na223ec2dcd8b47c681bda48333e1cbf5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Ubiquinone
146 rdf:type schema:DefinedTerm
147 Na4424cb6d09e4200935205ed52d2da8a rdf:first sg:person.016575557672.54
148 rdf:rest N02ce8eac42e143a987d36586082ee376
149 Na7405ff99ae04be4a8dd894d1aeddbf3 rdf:first sg:person.0771471774.72
150 rdf:rest Nb41092b8c6594b209d75dd997f40f286
151 Nac26607a13e648e2b432434fcfd58905 schema:issueNumber 1
152 rdf:type schema:PublicationIssue
153 Nb41092b8c6594b209d75dd997f40f286 rdf:first sg:person.01341064336.49
154 rdf:rest rdf:nil
155 Nb77eba3555664d879a8beab5d8b0274a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Dietary Supplements
157 rdf:type schema:DefinedTerm
158 Nbe9aacfc93a44258b855e8f4eccaf714 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Bifidobacterium longum
160 rdf:type schema:DefinedTerm
161 Nbfb4618834cb4f6abc67f2dcc7aa0894 schema:name pubmed_id
162 schema:value 30795775
163 rdf:type schema:PropertyValue
164 Nc0f3257a5f1840c1bf5b05e9df9350da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Middle Aged
166 rdf:type schema:DefinedTerm
167 Nd2bd8e461f8141d78d5f1fb42a390260 rdf:first sg:person.01042354223.41
168 rdf:rest Na7405ff99ae04be4a8dd894d1aeddbf3
169 Nd47302f0484d4e63abb9b3f339a40d17 schema:affiliation grid-institutes:grid.4708.b
170 schema:familyName Dall’Orto
171 schema:givenName Daria
172 rdf:type schema:Person
173 Ndba81f4fd5a94669ae02ac2df34c3eea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Niacin
175 rdf:type schema:DefinedTerm
176 Ne47f7c842eaf466298ee4abac467dc74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Adult
178 rdf:type schema:DefinedTerm
179 Nf46acd7bc88b48c8a25708372f58d821 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Biological Products
181 rdf:type schema:DefinedTerm
182 Nf73ddedf03eb4f1993fe505c04d60812 rdf:first sg:person.01313104616.27
183 rdf:rest Nd2bd8e461f8141d78d5f1fb42a390260
184 Nf87caea029804a47957f27e10f2085bd rdf:first sg:person.01331664466.13
185 rdf:rest Na4424cb6d09e4200935205ed52d2da8a
186 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
187 schema:name Medical and Health Sciences
188 rdf:type schema:DefinedTerm
189 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
190 schema:name Cardiorespiratory Medicine and Haematology
191 rdf:type schema:DefinedTerm
192 sg:journal.1031283 schema:issn 1475-2891
193 schema:name Nutrition Journal
194 schema:publisher Springer Nature
195 rdf:type schema:Periodical
196 sg:person.01042354223.41 schema:affiliation grid-institutes:None
197 schema:familyName Sirtori
198 schema:givenName Cesare R.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042354223.41
200 rdf:type schema:Person
201 sg:person.01134006757.62 schema:affiliation grid-institutes:None
202 schema:familyName Bosisio
203 schema:givenName Raffaella
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134006757.62
205 rdf:type schema:Person
206 sg:person.01152414131.16 schema:affiliation grid-institutes:grid.4708.b
207 schema:familyName Pavanello
208 schema:givenName Chiara
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152414131.16
210 rdf:type schema:Person
211 sg:person.01164502750.58 schema:affiliation grid-institutes:grid.4708.b
212 schema:familyName Ruscica
213 schema:givenName Massimiliano
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164502750.58
215 rdf:type schema:Person
216 sg:person.01207302233.42 schema:affiliation grid-institutes:grid.7563.7
217 schema:familyName Del Puppo
218 schema:givenName Marina
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207302233.42
220 rdf:type schema:Person
221 sg:person.01313104616.27 schema:affiliation grid-institutes:None
222 schema:familyName Mombelli
223 schema:givenName Giuliana
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313104616.27
225 rdf:type schema:Person
226 sg:person.01331664466.13 schema:affiliation grid-institutes:grid.4708.b
227 schema:familyName Macchi
228 schema:givenName Chiara
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331664466.13
230 rdf:type schema:Person
231 sg:person.01341064336.49 schema:affiliation grid-institutes:grid.420421.1
232 schema:familyName Magni
233 schema:givenName Paolo
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341064336.49
235 rdf:type schema:Person
236 sg:person.016575557672.54 schema:affiliation grid-institutes:grid.4708.b
237 schema:familyName Botta
238 schema:givenName Margherita
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016575557672.54
240 rdf:type schema:Person
241 sg:person.0600005230.87 schema:affiliation grid-institutes:grid.15667.33
242 schema:familyName Gandini
243 schema:givenName Sara
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600005230.87
245 rdf:type schema:Person
246 sg:person.0676162076.83 schema:affiliation grid-institutes:grid.7548.e
247 schema:familyName Bertolotti
248 schema:givenName Marco
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676162076.83
250 rdf:type schema:Person
251 sg:person.0771471774.72 schema:affiliation grid-institutes:grid.4708.b
252 schema:familyName Calabresi
253 schema:givenName Laura
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771471774.72
255 rdf:type schema:Person
256 sg:pub.10.1007/bf00294629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036979684
257 https://doi.org/10.1007/bf00294629
258 rdf:type schema:CreativeWork
259 sg:pub.10.1007/s11886-017-0848-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084808918
260 https://doi.org/10.1007/s11886-017-0848-8
261 rdf:type schema:CreativeWork
262 sg:pub.10.1007/s12325-017-0580-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090379297
263 https://doi.org/10.1007/s12325-017-0580-1
264 rdf:type schema:CreativeWork
265 sg:pub.10.1038/nrendo.2017.78 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090367122
266 https://doi.org/10.1038/nrendo.2017.78
267 rdf:type schema:CreativeWork
268 sg:pub.10.1038/sj.ejcn.1602910 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015359962
269 https://doi.org/10.1038/sj.ejcn.1602910
270 rdf:type schema:CreativeWork
271 sg:pub.10.1186/s12906-015-0576-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009756976
272 https://doi.org/10.1186/s12906-015-0576-9
273 rdf:type schema:CreativeWork
274 sg:pub.10.1186/s12937-016-0213-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047786796
275 https://doi.org/10.1186/s12937-016-0213-6
276 rdf:type schema:CreativeWork
277 grid-institutes:None schema:alternateName Centro Dislipidemie, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
278 schema:name Centro Dislipidemie, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
279 rdf:type schema:Organization
280 grid-institutes:grid.15667.33 schema:alternateName Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
281 schema:name Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
282 rdf:type schema:Organization
283 grid-institutes:grid.420421.1 schema:alternateName IRCCS MultiMedica, Sesto S. Giovanni, Milan, Italy
284 schema:name Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy
285 IRCCS MultiMedica, Sesto S. Giovanni, Milan, Italy
286 rdf:type schema:Organization
287 grid-institutes:grid.4708.b schema:alternateName Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro E. Grossi Paoletti, Università degli Studi di Milano, Milan, Italy
288 Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy
289 schema:name Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro E. Grossi Paoletti, Università degli Studi di Milano, Milan, Italy
290 Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy
291 rdf:type schema:Organization
292 grid-institutes:grid.7548.e schema:alternateName Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Università degli Studi di Modena e Reggio Emilia, Modena, Italy
293 schema:name Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Università degli Studi di Modena e Reggio Emilia, Modena, Italy
294 rdf:type schema:Organization
295 grid-institutes:grid.7563.7 schema:alternateName Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano Bicocca, Monza, Italy
296 schema:name Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano Bicocca, Monza, Italy
297 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...